Dr. Michael Artman, M.D., an expert in pediatric cardiac surgery at NYU Medical Center is available to comment on a new study that infants and young children with heart defects benefited from a milrinone, a drug they received shortly after cardiac surgery (Journal of the American Heart Association 2/25/03). According to the study, the drug significantly reduced the risk of low cardiac output syndrome (LCOS), a life threatening reduction in the heart's pumping ability.
Michael Artman, MD, is the Mitty Professor of Pediatric Surgery and Professor of Pediatrics, Physiology, Neuroscience, and Pharmacology and Director of the Division of Pediatric Cardiology at New York University School of Medicine.
"This is an important advancement that shapes the care of children post-operatively," says Dr. Artman.
Milrinone improves the heart's ability to squeeze and relax as well as lower blood pressure in blood vessels.
RSS